Outset Medical Sets Out To Upend Dialysis
Leslie Trigg didn’t design her Medtech career, but her pursuit of the right opportunities led her to a series of wildly successful start-ups including her recent venture, Outset Medical, creator of an innovative new dialysis system.
The first-time CEO recognized Outset’s potential as it seeks to bring change to an industry that has remained the same for decades. In this podcast, Trigg shares her early thoughts about Outset’s potential and what she’s learned along the way.
Trigg also takes the time to share some insights on what makes being a Medtech leader most meaningful.
Listen here: http://healthegy.com/outset-ceo-trigg-talks-dialysis-fundraising-and-what-makes-a-medtech-career-matter/
BEND, Ore. - St. Charles Bend announced Monday it is the first hospital in Oregon to offer a new treatment program for patients at risk for stroke due to blockages in their neck arteries.
Q1 Cash Balance of $156.9M — Cash Through Q3 2019
Phase 1a Study Will Assess Novel Checkpoint Inhibitor as a Single Agent in Solid Tumors
Outset Medical announced it received $76.5 million in Series C equity funding. A new investor, funds advised by T. Rowe Price Associates Inc., led the round, which also included participation from existing investors Fidelity Management & Research Company, Partner Fund Management LP, Warburg Pincus, Perceptive Advisors and The Vertical Group.
Via: Business Wire
Financing to Expand U.S. Commercial Introduction and Manufacturing